Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur J Hosp Pharm ; 29(2): 113-115, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34716170

RESUMEN

The case of a female who had an accident that caused an open fracture is reported. During hospitalisation, Verona integron-encoded metallo-ß-lactamase (VIM)-producing Klebsiella pneumoniae was isolated. Antimicrobial susceptibility testing revealed resistance to ß-lactam antibiotics, quinolones, trimethoprim/sulfamethoxazole, and susceptibility to tigecycline, colistin, fosfomycin and aminoglycosides. Synergistic activity of ceftazidime-avibactam and aztreonam was proved in vitro and a combined therapy with tigecycline was started. Combination with aminoglycosides was ruled out as it was not described in the literature and also in order to avoid side effects. Colistin was rejected because of its nephrotoxicity profile. The antibiotic treatment was assessed by a multidisciplinary team with a pharmacist who closely monitored adverse effects and interactions with other drugs. The total duration of this combination was 25 days, without any adverse events reported. Fourteen weeks after the accident the patient was discharged. After 2 months of follow-up neither relapses nor reinfections have been reported.


Asunto(s)
Aztreonam , Ceftazidima , Compuestos de Azabiciclo , Aztreonam/farmacología , Aztreonam/uso terapéutico , Ceftazidima/farmacología , Ceftazidima/uso terapéutico , Combinación de Medicamentos , Femenino , Humanos , Integrones , Klebsiella pneumoniae/metabolismo , Pruebas de Sensibilidad Microbiana , beta-Lactamasas/metabolismo , beta-Lactamasas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA